Universal Health Services (NYSE:UHS) posts Q3 2026 sales in line with estimates

Hospital management company Universal Health Services (NYSE:UHS) met Wall Street’s revenue expectations in Q3 2026, with revenue rising 5.3% year on year to $4.73 billion. Its non-GAAP profit of $5.22 per share was 1.3% above analysts’ consensus estimates.

For more on Universal Health Services, read our free full research report.

Revenue growth

Examining a company’s long-term performance can provide clues about its quality. Any business can deliver a good quarter or two, but the best consistently grow over the long term. Over the last five years, Universal Health Services grew its revenue at a decent 8.1% compounded annual growth rate. Its growth was slightly above the average healthcare company and shows its offerings resonate with customers.

Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Universal Health Services’s annualized revenue growth of 9.1% over the last two years is above its five-year trend, suggesting some bright spots.

The company’s same-store sales, which show how much revenue its established locations generate, offer a closer look at its revenue dynamics. Over the last two years, Universal Health Services’s same-store sales averaged 4.6% year-on-year growth. Revenue growth outpaced same-store sales growth, indicating that new locations are boosting the company’s revenue.

This quarter, Universal Health Services grew its revenue by 5.3% year on year, and its $4.73 billion of revenue was in line with Wall Street’s consensus estimates.

Looking ahead, sell-side analysts expect revenue to grow 4.8% over the next 12 months, according to S&P, a deceleration versus the last two years. This projection is underwhelming and indicates its products and services will see some demand headwinds.

Adjusted operating margin

Adjusted operating margin is a key measure of profitability. Think of it as net income (the bottom line) excluding the impact of non-recurring expenses, taxes and interest on debt – metrics less connected to business fundamentals.

Universal Health Services was profitable over the last five years but held back by its large cost base. Its average adjusted operating margin of 9.8% was weak for a healthcare business.

On the positive side, Universal Health Services’s adjusted operating margin rose by 3 percentage points over the last five years, as its revenue growth provided operating leverage. More recently, the company’s trajectory has remained intact, with its margin increasing by 1 percentage point on a two-year basis. These gains are a positive sign and indicate continued momentum.

In Q3, Universal Health Services generated an adjusted operating margin of 10.2%, down 1.4 percentage points year on year. This small reduction indicates the company’s overall cost structure has been relatively stable.

Earnings per share

Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth. For example, a company could inflate its revenue through excessive spending on advertising and promotions.

Universal Health Services’s EPS grew at a 12.7% compounded annual growth rate over the last five years, higher than its 8.1% annualized revenue growth. This indicates the company became more profitable on a per-share basis as it expanded.

A closer look at Universal Health Services’s earnings quality helps explain the drivers of its performance. As mentioned earlier, Universal Health Services’s adjusted operating margin declined this quarter but expanded by 3 percentage points over the last five years. Its share count also shrank by 29.3%, and these factors together are positive signs for shareholders because improving profitability and share buybacks boost EPS growth relative to revenue growth.

In Q3, Universal Health Services reported adjusted EPS of $5.22, down from $5.69 in the same quarter last year. Despite falling year on year, EPS beat analysts’ consensus estimates by 1.3%. Over the next 12 months, Wall Street expects Universal Health Services’s full-year EPS to grow 3% from $22.70 to $23.38, according to S&P.

Key takeaways from Universal Health Services’s Q3 results

Universal Health Services reported in line Q3 revenue and adjusted EPS, but adjusted EBITDA fell short of expectations. Overall, it was a mixed quarter. Shares remained flat at $176.50 immediately after the report.

To assess whether Universal Health Services is a buy, consider its valuation, business quality and latest earnings. For more, read our full research report here (it’s free).